The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.
about
The cilia-regulated proteasome and its role in the development of ciliopathies and cancerUbiquitin proteasome system research in gastrointestinal cancerMolecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc.Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer.Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumorsCentromere fission, not telomere erosion, triggers chromosomal instability in human carcinomas.Cytosolic Hsp60 can modulate proteasome activity in yeastAn anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladder.Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.Stably Expressed Genes Involved in Basic Cellular Functions.Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage.Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer.Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen speciesAPEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome.Regulation of metformin response by breast cancer associated gene 2.Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss.Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin.Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspectsSynthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles.The destruction complex of beta-catenin in colorectal carcinoma and colonic adenoma.Novel green synthesis of gold nanoparticles using Citrullus lanatus rind and investigation of proteasome inhibitory activity, antibacterial, and antioxidant potentialLinear ubiquitin chain induces apoptosis and inhibits tumor growth.Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy.MicroRNA-300 Regulates the Ubiquitination of PTEN through the CRL4BDCAF13 E3 Ligase in Osteosarcoma Cells.ZGDHu-1 for cancer therapy.Proteasome inhibitory, antioxidant, and synergistic antibacterial and anticandidal activity of green biosynthesized magnetic Fe3O4 nanoparticles using the aqueous extract of corn (Zea mays L.) ear leaves.Potential use of chymotrypsin-like proteasomal activity as a biomarker for prostate cancer.Role of the ubiquitin/proteasome system on ACTH turnover in rat corticotropes.PSMD7 downregulation induces apoptosis and suppresses tumorigenesis of esophageal squamous cell carcinoma via the mTOR/p70S6K pathway.
P2860
Q26746930-3BA8D0D2-14A9-45C8-B567-ADAE2064753EQ26766683-E494CAAB-896E-43B4-99B3-6431542D23FEQ33706956-110C66FB-3D3D-4A08-B0D7-7E9FBC5627AAQ33956292-CFB9328B-A10F-475B-A7E4-1C9816E8AC94Q34195083-599876E9-610D-4DCE-A964-40B701955794Q34218976-84D2F85F-7693-43BE-97A0-D499A3AFC60DQ35020477-74DA44A9-7F22-4FE0-98D1-FEE78E62D2DCQ35055563-4EC3A983-8650-4A1E-952E-DA0831D9EF8AQ35151905-77C20BA8-D59B-46FE-B8BF-02433FF5056BQ35836881-2A801F30-11EF-46AC-9E3F-E92CA0D5B4ACQ36261258-C14AD6FD-F3D0-4CB8-B19C-C8CA8F1B6A08Q36558030-3D7E8F09-E2DB-4C7A-A750-93C2EDCB5F8BQ37096504-1B8D2FEE-7738-4651-8D52-DC55A306FBDDQ37309407-C021899F-D933-4FE8-95D3-80365FF935CDQ37377197-2A3969A8-22B2-449A-9F65-79614A010E09Q37448089-5045FA06-D867-43FB-A626-501C1D3D9546Q37589832-D7C2E9A9-8DA7-4C4A-8636-8AEC30C84E9DQ37680263-F23D820E-6F19-4130-99BE-726CEF824246Q37948056-70545068-8A28-41DB-9B3D-C9341D78929CQ38787197-FA066A52-2CC1-43B3-BFB8-8D14812FDBE2Q38809124-963F44C2-0054-4563-8873-D26E22FA09C2Q39490162-07945BBF-B7D5-4B4A-90F9-F75151E26549Q42013222-B448222B-CCA8-4036-B2F3-935521CEEDB6Q42034676-BD85EDD2-BC7C-4269-87C9-4C217E2DD598Q48219956-AD1BA316-8EF8-4786-9D09-4838D95989A1Q48834531-2479211B-BFDC-4C36-AA1A-C72E20436960Q49396643-1BBDB641-971D-4AD0-AA41-DDF74E70D24EQ49436424-D6234F94-7A95-4CFA-95A8-B047112E9E2BQ50428427-7AA87729-906B-4D62-BACD-06245F20184DQ52351127-060AAD3A-1523-411F-AD85-4F83D2FDDAB3Q52656860-2D45D636-58E6-4AA6-84D2-1D3F23C8012AQ52720455-B385E913-1F82-43B0-8F6F-D047CB54B4F5
P2860
The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The ubiquitin-proteasome syste ...... ncer treatment and prevention.
@ast
The ubiquitin-proteasome syste ...... ncer treatment and prevention.
@en
type
label
The ubiquitin-proteasome syste ...... ncer treatment and prevention.
@ast
The ubiquitin-proteasome syste ...... ncer treatment and prevention.
@en
prefLabel
The ubiquitin-proteasome syste ...... ncer treatment and prevention.
@ast
The ubiquitin-proteasome syste ...... ncer treatment and prevention.
@en
P2860
P1476
The ubiquitin-proteasome syste ...... ncer treatment and prevention.
@en
P2093
P2860
P304
P356
10.2174/138920310791824057
P577
2010-09-01T00:00:00Z